Cardiovascular diseases
This page brings together the European Medicines Agency's (EMA) latest information on diseases affecting the heart and blood vessels.
It lists the following:
EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its December 2023 meeting.
PRAC recommends measures to minimise the risk of serious side effects with medicines containing pseudoephedrine.
EMA’s human medicines committee (CHMP) recommended eight medicines.
Currently, we have no events for this therapeutic area.